Monday, 21 October 2019

Pharma News

  • Is India suffering from drug pipeline deficit?

    Pharma |  Analysis | By Rahul Koul Koul | 0 Comment | 15 Jan, 2013

    It is estimated that about 40-to-60 percent of the Indian population still doesn't have access to vital life saving drugs. The looming threat of increased mortality rate due to various dise...Read more

  • Bayer seeks nod for Trap-Eye in Japan

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: Bayer HealthCare announced that Bayer Yakuhin, Osaka, Japan, has submitted an application for marketing authorization for VEGF Trap-Eye (aflibercept solution for injection) for ...Read more

  • Health awareness is fueling diagnostics in Asia

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2012

    Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche Diagnostics began its journey in Indi...Read more

  • Novartis eye care firm gets EU nod for Jetrea

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval for Jetrea intravitreal injection (ocriplasmin) in the EU for the tre...Read more

  • Otsuka schizophrenia drug seeks EMA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Dec, 2012

    Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the approval of aripiprazole depot formulation has been accepted by the Euro...Read more

  • Cancer drug Ibrutinib gets FDA 'Breakthrough' tag

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

    Singapore: The US FDA has granted 'Breakthrough Therapy Designations' for Janssen Research and Development's investigational oral agent ibrutinib, which is used as a monotherapy for B-cell ...Read more

  • Mylan Q2 2012 results out, grows 15%

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Singapore: Mylan reported its financial results for the three and six months ending on June 30, 2012. The company's adjusted diluted EPS was $0.60 for the three months ending June 30, 2012 ...Read more

  • Tai Tien markets pitavastatin calcium in Taiwan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: Tai Tien Pharmaceuticals, a wholly owned subsidiary of Japan-based Mitsubishi Tanabe Pharmaceutical, has started marketing of pitavastatin calcium (Livalo tablets), a hypercholes...Read more

  • FDA nod for Aurobindo generic migraine tablets

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Bangalore: The US FDA granted final approval to India-based Aurobindo Pharma to manufacture and market rizatriptan benzoate tablets used in the treatment of migraine. The product, which is ...Read more

  • Lupin, Aurobindo get approval for HIV drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Bangalore: Pharma majors Lupin and Aurobindo have announced that they have received approvals for their respective generic versions of Combivir tablets used in the treatment of HIV. Aurobin...Read more

  • Gilead HIV/AIDS 'blood booster' gets EU nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

    Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobicistat 150 mg tablets), a pharmacokinetic enhancer that boosts blood ...Read more

  • Can-Fite APIs to be manufactured by China CRO

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

    Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF102 are up-scaled and manufactured by Chemspec, a leading Chinese CRO....Read more

  • Merck, AstraZeneca sign deal for cancer drug therapy

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in phase IIa cli...Read more

  • China vitamin C manufacturer fined by US court

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

    Singapore: A US court has fined North China Pharmaceutical (NCPC), a vitamin C manufacturer and antibiotics supplier, $162 million for price fixing. This is the first time that a Chinese dr...Read more

  • Inversion of ibuprofen in body helps fight cancer: Study

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inflammatory drug ibuprofen might stop certain cancers from developing. ...Read more

  • Daewoong buys China's Liaoning Baifeng for $20 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Daewoong Pharmaceutical is going to acquire Liaoning Baifeng, a Shenyang (Liaoning Province)-based manufacturer of drug materials, and invest up to $20 million (18 billion won) t...Read more

  • India to review its pharma FDI policies

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    New Delhi: The Indian government will be reviewing the foreign direct investment (FDI) policies for the pharmaceutical industry in the country at the end of the month in a high level meetin...Read more

  • Ms Sarah Rickwood, IMS Health: Savings from generics will start to decline in 2013

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

    The changing outlook for biosimilars comes at a time when the global pharmaceutical market is feeling the combined impact of two key events: a period of unprecedented patent expirations on ...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls